NGM Biopharmaceuticals Inc (NGM)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 128.53M
P/E Ratio
0.00
Revenue (TTM)
$ 4.42M
Volume
0
52W High
$ 0.00
52W Low
$ 0.00
Dividend Yield
0.00%
Beta
1.26
Technicals
50-Day MA
1.5521
200-Day MA
1.4719
52 Week High
N/A
52 Week Low
N/A
About NGM
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer.
Employees
138
Headquarters
South San Francisco, CA
CEO
Mr. William J. Rieflin J.D.